Improvement of platelet preservation by inhibition of TRPC6
Transfusion Medicine · 2023
DOI: 10.1111/tme.12955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion Medicine, 2023. Verfasst von Yuanjia Tan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, China Three Gorges University, Yichang, China. Hauptthemen laut MEDLINE: Blood Platelets, Platelet Aggregation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: The Weigao Science Foundation of the Chinese Society of Blood Transfusion.
Abstract (Originalsprache)
Background
The preservation of platelets (PLTs) by room temperature (RT) oscillation limits their shelf life to between 4 and 7 days because of the decrease in PLT function. TRPC6 is a non‐selective mechanically sensitive cation channel that has been shown to mediate Ca 2+ signalling, implying a role in PLT activation during preservation by RT oscillation.
Objectives
This study was designed to investigate whether inhibition of TRPC6 can improve the RT preservation of PLTs and the possible underlying mechanism.
Methods
Human PLTs from whole blood were stored at 22 ± 2°C with oscillation in plasma or M‐sol (mixture of solutions). BI‐749327, a specific TRPC6 inhibitor, was administered throughout the preservation period. PLT distribution width (PDW), mean platelet volume (MPV), maximum platelet aggregation rate (MAR) and average aggregation rate (AAR) were measured. The MTT method was used to assess the relative viability of PLTs. Flow cytometry was used to measure the changes of Ca 2+ concentration in PLTs and phosphatidylserine (PS) exposure on the PLT surface, and western blotting was used to assess the expression changes of platelet TRPC6 and CD62P proteins.
Results
Compared with the control group, inhibition of TRPC6 with BI‐749327 significantly reduced the PDW, MPV and Ca 2+ concentration, the MAR and AAR were significantly increased, the expression of TRPC6 and CD62P protein was significantly down‐regulated in PLTs, and the PS exposure was significantly reduced on the PLT surface. However, these effects were all reversed by activation of TRPC6.
Conclusion
Inhibition of TRPC6 improves the quality of PLT preservation by inhibiting the Ca 2+ signal mediated by TRPC6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Third-Grade Pharmacological Laboratory on Traditional Chinese Medicine, China Three Gorges University, Yichang, China.
- Department of Physiology, Medical College of China Three Gorges University, Yichang, China.
- Office, The Blood Bank Center of Yichang City, Yichang, China.
- Department of Hematology, Yichang Central People' Hospital, The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
ORCID-Profile: Yuanjia Tan
Förderung
- The Weigao Science Foundation of the Chinese Society of Blood Transfusion
Zitieren
APA
Tan, Y., Lu, W., Yi, X., Cai, H., Yuan, Y., & Zhang, S. (2023). Improvement of platelet preservation by inhibition of TRPC6. Transfusion Medicine. https://doi.org/10.1111/tme.12955
Vancouver
Tan Y, Lu W, Yi X, Cai H, Yuan Y, Zhang S. Improvement of platelet preservation by inhibition of TRPC6. Transfusion Medicine. 2023. doi:10.1111/tme.12955
BibTeX
@article{Tan2023,
author = {Tan, Yuanjia and Lu, Wei and Yi, Xiaomei and Cai, Huili and Yuan, Yurong and Zhang, Shizhong},
title = {Improvement of platelet preservation by inhibition of TRPC6},
journal = {Transfusion Medicine},
year = {2023},
doi = {10.1111/tme.12955}
}
EUVIMED